What does weighted-average volatility mean?

This metric represents the estimated standard deviation of the company's stock price returns used in valuation models for equity-based compensation. It reflects the market's perception of the uncertainty and risk associated with the company's future equity performance.

Ardent Health Partners ARDT Weighted-average volatility

Weighted-average volatility at other companies

Bicara TherapeuticsBCAX

90.8%—

ZymeworksZYME

63.1%0.0pp

KEE

Keel Infrastructure Corp. Common StockKEEL

75%-5.0pp

GATXGATX

24.9%-1.0pp

Healthcare Services GroupHCSG

42.1%+1.6pp

AshlandASH

27.3%+1.3pp

Other financials

Income statement

See full

Revenue$1.6B+7.0%

Gross profit$1.6B+6.7%

Net income$39.9M-3.7%

EPS (diluted)$0.28-3.4%

Balance sheet

See full

Cash & equivalents$609.7M+23.2%

Total debt$1.2B+1.7%

Total equity$1.3B+13.8%

Total assets$5.3B+7.0%

Cash flow

See full

Operating cash flow-$60.2M-143%

CapEx$28.1M+22.6%

Free cash flow-$88.3M-85.2%

Valuation

See full

Market cap$1.35B-37.7%

Enterprise value$1.91B-31.9%

P/E10×+0.4×

P/S0.2×-0.1×

Profitability

See full

Gross margin97.5%-0.1pp

Net margin2.1%-1.6pp

FCF margin3.4%+1.4pp

Returns & leverage

See full

Return on equity10.7%-9.0pp

Debt / equity0.9×-0.1×

Current ratio2.1×0.0×

Where this comes from

Reported directly by Ardent Health Partners in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate.

The official record: Ardent Health Partners’s 10-K, filed March 16, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardent Health Partners's weighted-average volatility.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ardent Health Partners's weighted-average volatility?: Ardent Health Partners (ARDT) reported weighted-average volatility of 60% in Q3 2024.
What does weighted-average volatility mean?: This metric represents the estimated standard deviation of the company's stock price returns used in valuation models for equity-based compensation. It reflects the market's perception of the uncertainty and risk associated with the company's future equity performance.